We are live on ! Find out more
CLYM

Climb Bio
CLYM

76 hedge funds and large institutions have $63.4M invested in Climb Bio in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 23

5% less funds holding

Funds holding: 80 → 76 (-4)

5.9% less ownership

Funds ownership: 82.87% → 76.97% (-5.9%)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

37% less capital invested

Capital invested by funds: $100M → $63.4M (-$36.9M)

Holders
76
Holders Change
-4
Holders Change %
-5%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
23
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$2.96M
2
CF
Cantor Fitzgerald
New York
+$2.19M
3
AAA
Affinity Asset Advisors
New York
+$1.62M
4
TCM
Tang Capital Management
California
+$1.62M
5
PLC
Peapod Lane Capital
New York
+$898K

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.72M
2
SB
Samsara BioCapital
California
-$4.7M
3
BCM
Boxer Capital Management
California
-$3.99M
4
Bank of America
Bank of America
North Carolina
-$1.62M
5
ABG
Ally Bridge Group
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
26
Ikarian Capital
Texas
$214K – – –
PAP
27
Persistent Asset Partners
Hong Kong
$178K – – –
BCM
28
Boxer Capital Management
California
$177K -$3.99M -2,458,190 -94%
BCM
29
Bridgeway Capital Management
Texas
$164K +$218K +134,300 New
Goldman Sachs
30
Goldman Sachs
New York
$147K -$7.4K -4,562 -4%
ACM
31
ADAR1 Capital Management
Texas
$146K +$115K +71,195 +148%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$139K +$3.73K +2,300 +2%
TD Asset Management
33
TD Asset Management
Ontario, Canada
$109K – – –
Citadel Advisors
34
Citadel Advisors
Florida
$101K +$26.4K +16,282 +24%
Charles Schwab
35
Charles Schwab
California
$85.5K – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$79.2K – – –
Millennium Management
37
Millennium Management
New York
$77.3K +$103K +63,379 New
Barclays
38
Barclays
United Kingdom
$71.7K +$14.5K +8,926 +18%
BFM
39
Boothbay Fund Management
New York
$65.5K – – –
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$51.9K +$45.8K +28,260 +198%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$49K +$1.99K +1,225 +3%
N
42
Nuveen
North Carolina
$47.6K – – –
Bank of America
43
Bank of America
North Carolina
$45.5K -$1.62M -996,405 -96%
XT
44
XTX Topco
Cayman Islands
$33.7K +$44.9K +27,660 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$30.2K -$11.4K -7,054 -22%
AQR Capital Management
46
AQR Capital Management
Connecticut
$26.6K -$5.47K -3,373 -13%
IIM
47
INTECH Investment Management
Florida
$25.6K +$11.9K +7,321 +53%
Mirae Asset Global ETFs Holdings
48
Mirae Asset Global ETFs Holdings
Hong Kong
$21.5K +$1.27K +786 +5%
HSBC Holdings
49
HSBC Holdings
United Kingdom
$21.4K -$36 -22 -0.1%
Wells Fargo
50
Wells Fargo
California
$21.3K +$628 +387 +2%
1
2
3 4

CLYM Hedge Fund Activity: Q1 2025 in Review

76 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q1 2025, worth a combined $63.4M — down 37% from $100M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CLYM and 10 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 23 added.

The largest buyer was Citigroup, adding an estimated $2.96M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $5.72M sold.

  • 76 institutional investors held Climb Bio (CLYM) as of Q1 2025, down from 80 in Q4 2024.
  • Funds reported $63.4M of Climb Bio stock for Q1 2025, down 37% quarter-over-quarter.
  • 10 funds opened new Climb Bio positions in Q1 2025 and 14 closed out, a net change of -4 holders.
  • The largest Climb Bio buyer in Q1 2025 was Citigroup, an estimated $2.96M added.
  • The largest Climb Bio seller in Q1 2025 was Janus Henderson Group, an estimated $5.72M sold.

Based on aggregated 13F filings for Q1 2025.